BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36920244)

  • 21. The effect of halofuginone lactate on experimental Cryptosporidium parvum infections in calves.
    Naciri M; Mancassola R; Yvoré P; Peeters JE
    Vet Parasitol; 1993 Jan; 45(3-4):199-207. PubMed ID: 8447063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
    Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel treatment strategies and drugs in development for cryptosporidiosis.
    Chavez MA; White AC
    Expert Rev Anti Infect Ther; 2018 Aug; 16(8):655-661. PubMed ID: 30003818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection.
    Arnold SLM; Choi R; Hulverson MA; Schaefer DA; Vinayak S; Vidadala RSR; McCloskey MC; Whitman GR; Huang W; Barrett LK; Ojo KK; Fan E; Maly DJ; Riggs MW; Striepen B; Van Voorhis WC
    J Infect Dis; 2017 Jul; 216(1):55-63. PubMed ID: 28541457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Cryptosporidium parvum in dairy calves and GP60 subtyping of diarrheic calves in central Argentina.
    Lombardelli JA; Tomazic ML; Schnittger L; Tiranti KI
    Parasitol Res; 2019 Jul; 118(7):2079-2086. PubMed ID: 31187226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common Molecular Targets of a Quinolone Based Bumped Kinase Inhibitor in
    Müller J; Anghel N; Imhof D; Hänggeli K; Uldry AC; Braga-Lagache S; Heller M; Ojo KK; Ortega-Mora LM; Van Voorhis WC; Hemphill A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216497
    [No Abstract]   [Full Text] [Related]  

  • 27. Protection of calves against cryptosporiosis by oral inoculation with gamma-irradiated Cryptosporidium parvum oocysts.
    Jenkins M; Higgins J; Kniel K; Trout J; Fayer R
    J Parasitol; 2004 Oct; 90(5):1178-80. PubMed ID: 15562625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts.
    Ahmed SA; El-Mahallawy HS; Karanis P
    Parasitol Res; 2019 Jul; 118(7):2053-2063. PubMed ID: 31187224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.
    Asadpour M; Namazi F; Razavi SM; Nazifi S
    Exp Parasitol; 2018 Dec; 195():59-65. PubMed ID: 30385266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two Novel Calcium-Dependent Protein Kinase 1 Inhibitors Interfere with Vertical Transmission in Mice Infected with Neospora caninum Tachyzoites.
    Müller J; Aguado-Martínez A; Balmer V; Maly DJ; Fan E; Ortega-Mora LM; Ojo KK; Van Voorhis WC; Hemphill A
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis.
    Müller J; Aguado-Martínez A; Ortega-Mora LM; Moreno-Gonzalo J; Ferre I; Hulverson MA; Choi R; McCloskey MC; Barrett LK; Maly DJ; Ojo KK; Van Voorhis W; Hemphill A
    J Antimicrob Chemother; 2017 Aug; 72(8):2334-2341. PubMed ID: 28486633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein.
    Perryman LE; Kapil SJ; Jones ML; Hunt EL
    Vaccine; 1999 Apr; 17(17):2142-9. PubMed ID: 10367947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of inhibitors for two glycolytic enzymes portrays high synergistic efficacy against
    Khan SM; Bajwa MR; Lahar RY; Witola WH
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0056923. PubMed ID: 37655889
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduced treatment frequencies with bumped kinase inhibitor 1369 are effective against porcine cystoisosporosis.
    Shrestha A; Ruttkowski B; Greber P; Whitman GR; Hulverson MA; Choi R; Michaels SA; Ojo KK; Van Voorhis WC; Joachim A
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():37-45. PubMed ID: 32861205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calf-level risk factors for neonatal diarrhea and shedding of Cryptosporidium parvum in Ontario dairy calves.
    Trotz-Williams LA; Wayne Martin S; Leslie KE; Duffield T; Nydam DV; Peregrine AS
    Prev Vet Med; 2007 Nov; 82(1-2):12-28. PubMed ID: 17602767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of the bumped kinase inhibitor BKI-1708 against the cyst-forming apicomplexan parasites Toxoplasma gondii and Neospora caninum in vitro and in experimentally infected mice.
    de Sousa MCF; Imhof D; Hänggeli KPA; Choi R; Hulverson MA; Arnold SLM; Van Voorhis WC; Fan E; Roberto SS; Ortega-Mora LM; Hemphill A
    Int J Parasitol Drugs Drug Resist; 2024 Jun; 25():100553. PubMed ID: 38917582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases.
    Van Voorhis WC; Hulverson MA; Choi R; Huang W; Arnold SLM; Schaefer DA; Betzer DP; Vidadala RSR; Lee S; Whitman GR; Barrett LK; Maly DJ; Riggs MW; Fan E; Kennedy TJ; Tzipori S; Doggett JS; Winzer P; Anghel N; Imhof D; Müller J; Hemphill A; Ferre I; Sanchez-Sanchez R; Ortega-Mora LM; Ojo KK
    Vet Parasitol; 2021 Jan; 289():109336. PubMed ID: 33418437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
    Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics.
    Riggs MW; Schaefer DA
    Methods Mol Biol; 2020; 2052():253-282. PubMed ID: 31452167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.